Naphthylpiperazinyl compounds useful for treating 5HT.sub.2B receptor mediated conditions
US5736544A · kind A · utility
4Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 1996 |
| Grant date | Apr 7, 1998 |
| Priority date | — |
| Expiry date | Mar 25, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for binding a 5-HT.sub.2B receptor in mammals using both known and novel compounds. Further, the invention provides a method for treating or preventing 5-HT.sub.2B related conditions. Finally, the invention provides an article of manufacture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.